Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MYL3 |
| Upstream (Parents) |
|---|
| (<<) ACTN3 → MYL3 |
| (<<) ALPP → MYL3 |
| (<<) COX6A2 → MYL3 |
| (<<) KREMEN2 → MYL3 |
| (<<) NAB2 → MYL3 |
| (<<) SGCA → MYL3 |
| (<<) SLC25A32 → MYL3 |
| (<<) STAT5B → MYL3 |
| (<<) TPM2 → MYL3 |
| Downstream (Children) |
|---|
| MYL3 → CSF2 (>>) |
| MYL3 → GNRH2 (>>) |
| MYL3 → NRN1 (>>) |
| MYL3 → PPIB (>>) |
| MYL3 → SOS2 (>>) |
| MYL3 → TPM1 (>>) |
| MYL3 → TPM3 (>>) |
